Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Dermatol. Aug 2, 2014; 3(3): 64-72
Published online Aug 2, 2014. doi: 10.5314/wjd.v3.i3.64
Figure 2
Figure 2 Immunostaining for cyclobutane pyrimidine dimers following oral exposure to d-limonene. Skin samples were collected 5 min after UVR exposure. (A) Only unstained, CPD-negative cells are seen in control epidermis (B) intense CPD-stained nuclei are seen in skin samples (C, D). Oral d-limonene prevented CPD photoproducts formation in dose-dependent manner. UVR: Ultraviolet irradiation; CPD: Cyclobutane pyrimidine dimer.